Pfizer’s coronavirus oral antiviral pill could be game changer: A ‘really important weapon’ as infections surge

CEID Faculty Dr. David Hamer offers his thoughts on the Phase 2/3 studies of Pfizer’s COVID-19 oral antiviral.